bioMérieux Triples Philly Footprint with 32,000 sq. ft. Predictive Diagnostics Innovation Center
bioMérieux has announced the lease signing of a new, 32,000 square foot (sq. ft.) state-of-the-art molecular innovation center at the Navy Yard in Philadelphia, Pennsylvania. In addition to supporting legacy molecular solutions that have been supplied to diverse beverage and food customers worldwide, the new site will house bioMérieux’s rapidly growing xPRO™ Program, as well as the company’s Predictive Diagnostics Innovation Center.
Since 2019, the xPRO™ Program has continuously developed innovative testing solutions that reduce food and beverage safety pain points across the entirety of the production process, from raw materials to final quality assurance releases. Development of an average molecular assay is a laborious process that takes 2–3 years to release into the market. bioMérieux’s xPRO™ team comes alongside industry heavyweights to solve their problems in as little as 90 days.